Global Artemisinine Market Research Report 2021

1 Artemisinine Market Overview
1.1 Product Overview and Scope of Artemisinine
1.2 Artemisinine Segment by Type
1.2.1 Global Artemisinine Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 Extraction from Artemisia annua
1.2.3 Semisynthetic Artemisinine
1.3 Artemisinine Segment by Application
1.3.1 Artemisinine Sales Comparison by Application: (2021-2027)
1.3.2 Injections
1.3.3 Tablets
1.3.4 Others
1.4 Global Artemisinine Market Size Estimates and Forecasts
1.4.1 Global Artemisinine Revenue 2016-2027
1.4.2 Global Artemisinine Sales 2016-2027
1.4.3 Artemisinine Market Size by Region: 2016 Versus 2021 Versus 2027

2 Artemisinine Market Competition by Manufacturers
2.1 Global Artemisinine Sales Market Share by Manufacturers (2016-2021)
2.2 Global Artemisinine Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Artemisinine Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Artemisinine Manufacturing Sites, Area Served, Product Type
2.5 Artemisinine Market Competitive Situation and Trends
2.5.1 Artemisinine Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Artemisinine Players Market Share by Revenue
2.5.3 Global Artemisinine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Artemisinine Retrospective Market Scenario by Region
3.1 Global Artemisinine Retrospective Market Scenario in Revenue by Region: 2016-2021
3.2 Global Artemisinine Retrospective Market Scenario in Sales by Region: 2016-2021
3.3 North America Artemisinine Market Facts & Figures by Country
3.3.1 North America Artemisinine Sales by Country
3.3.2 North America Artemisinine Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Artemisinine Market Facts & Figures by Country
3.4.1 Europe Artemisinine Sales by Country
3.4.2 Europe Artemisinine Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Artemisinine Market Facts & Figures by Region
3.5.1 Asia Pacific Artemisinine Sales by Region
3.5.2 Asia Pacific Artemisinine Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Artemisinine Market Facts & Figures by Country
3.6.1 Latin America Artemisinine Sales by Country
3.6.2 Latin America Artemisinine Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Artemisinine Market Facts & Figures by Country
3.7.1 Middle East and Africa Artemisinine Sales by Country
3.7.2 Middle East and Africa Artemisinine Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Artemisinine Historic Market Analysis by Type
4.1 Global Artemisinine Sales Market Share by Type (2016-2021)
4.2 Global Artemisinine Revenue Market Share by Type (2016-2021)
4.3 Global Artemisinine Price by Type (2016-2021)

5 Global Artemisinine Historic Market Analysis by Application
5.1 Global Artemisinine Sales Market Share by Application (2016-2021)
5.2 Global Artemisinine Revenue Market Share by Application (2016-2021)
5.3 Global Artemisinine Price by Application (2016-2021)

6 Key Companies Profiled
6.1 Guilin Pharmaceutical
6.1.1 Guilin Pharmaceutical Corporation Information
6.1.2 Guilin Pharmaceutical Description and Business Overview
6.1.3 Guilin Pharmaceutical Artemisinine Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Guilin Pharmaceutical Product Portfolio
6.1.5 Guilin Pharmaceutical Recent Developments/Updates
6.2 CAT KHANH
6.2.1 CAT KHANH Corporation Information
6.2.2 CAT KHANH Description and Business Overview
6.2.3 CAT KHANH Artemisinine Sales, Revenue and Gross Margin (2016-2021)
6.2.4 CAT KHANH Product Portfolio
6.2.5 CAT KHANH Recent Developments/Updates
6.3 Novanat Bioresource
6.3.1 Novanat Bioresource Corporation Information
6.3.2 Novanat Bioresource Description and Business Overview
6.3.3 Novanat Bioresource Artemisinine Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Novanat Bioresource Product Portfolio
6.3.5 Novanat Bioresource Recent Developments/Updates
6.4 BEEPZ
6.4.1 BEEPZ Corporation Information
6.4.2 BEEPZ Description and Business Overview
6.4.3 BEEPZ Artemisinine Sales, Revenue and Gross Margin (2016-2021)
6.4.4 BEEPZ Product Portfolio
6.4.5 BEEPZ Recent Developments/Updates
6.5 KPC Pharmaceuticals
6.5.1 KPC Pharmaceuticals Corporation Information
6.5.2 KPC Pharmaceuticals Description and Business Overview
6.5.3 KPC Pharmaceuticals Artemisinine Sales, Revenue and Gross Margin (2016-2021)
6.5.4 KPC Pharmaceuticals Product Portfolio
6.5.5 KPC Pharmaceuticals Recent Developments/Updates
6.6 BIONEXX
6.6.1 BIONEXX Corporation Information
6.6.2 BIONEXX Description and Business Overview
6.6.3 BIONEXX Artemisinine Sales, Revenue and Gross Margin (2016-2021)
6.6.4 BIONEXX Product Portfolio
6.6.5 BIONEXX Recent Developments/Updates
6.7 Guangxi xiancaotang
6.6.1 Guangxi xiancaotang Corporation Information
6.6.2 Guangxi xiancaotang Description and Business Overview
6.6.3 Guangxi xiancaotang Artemisinine Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Guangxi xiancaotang Product Portfolio
6.7.5 Guangxi xiancaotang Recent Developments/Updates
6.8 Sanofi
6.8.1 Sanofi Corporation Information
6.8.2 Sanofi Description and Business Overview
6.8.3 Sanofi Artemisinine Sales, Revenue and Gross Margin (2016-2021)
6.8.4 Sanofi Product Portfolio
6.8.5 Sanofi Recent Developments/Updates
6.9 Natural Bio-engineering
6.9.1 Natural Bio-engineering Corporation Information
6.9.2 Natural Bio-engineering Description and Business Overview
6.9.3 Natural Bio-engineering Artemisinine Sales, Revenue and Gross Margin (2016-2021)
6.9.4 Natural Bio-engineering Product Portfolio
6.9.5 Natural Bio-engineering Recent Developments/Updates
6.10 Kerui nanhai
6.10.1 Kerui nanhai Corporation Information
6.10.2 Kerui nanhai Description and Business Overview
6.10.3 Kerui nanhai Artemisinine Sales, Revenue and Gross Margin (2016-2021)
6.10.4 Kerui nanhai Product Portfolio
6.10.5 Kerui nanhai Recent Developments/Updates

7 Artemisinine Manufacturing Cost Analysis
7.1 Artemisinine Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Artemisinine
7.4 Artemisinine Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Artemisinine Distributors List
8.3 Artemisinine Customers

9 Artemisinine Market Dynamics
9.1 Artemisinine Industry Trends
9.2 Artemisinine Growth Drivers
9.3 Artemisinine Market Challenges
9.4 Artemisinine Market Restraints

10 Global Market Forecast
10.1 Artemisinine Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Artemisinine by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Artemisinine by Type (2022-2027)
10.2 Artemisinine Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Artemisinine by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Artemisinine by Application (2022-2027)
10.3 Artemisinine Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Artemisinine by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Artemisinine by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer

List of Tables
Table 1. Global Artemisinine Sales (K Units) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Artemisinine Sales (K Units) Comparison by Application (2021-2027)
Table 3. Global Artemisinine Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Artemisinine Covered in This Study
Table 5. Global Artemisinine Sales (K Units) of Key Manufacturers (2016-2021)
Table 6. Global Artemisinine Sales Share by Manufacturers (2016-2021)
Table 7. Global Artemisinine Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Artemisinine Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Artemisinine Average Price (USD/Unit) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Artemisinine Manufacturing Sites and Area Served
Table 11. Manufacturers Artemisinine Product Type
Table 12. Global Artemisinine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Artemisinine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Artemisinine as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Artemisinine Sales by Region (2016-2021) & (K Units)
Table 16. Global Artemisinine Sales Market Share by Region (2016-2021)
Table 17. Global Artemisinine Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Artemisinine Sales by Country (2016-2021) & (K Units)
Table 19. North America Artemisinine Sales Market Share by Country (2016-2021)
Table 20. North America Artemisinine Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Artemisinine Revenue Market Share by Country (2016-2021)
Table 22. Europe Artemisinine Sales by Country (2016-2021) & (K Units)
Table 23. Europe Artemisinine Sales Market Share by Country (2016-2021)
Table 24. Europe Artemisinine Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Artemisinine Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Artemisinine Sales by Region (2016-2021) & (K Units)
Table 27. Asia Pacific Artemisinine Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Artemisinine Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Artemisinine Revenue Market Share by Region (2016-2021)
Table 30. Latin America Artemisinine Sales by Country (2016-2021) & (K Units)
Table 31. Latin America Artemisinine Sales Market Share by Country (2016-2021)
Table 32. Latin America Artemisinine Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Artemisinine Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Artemisinine Sales by Country (2016-2021) & (K Units)
Table 35. Middle East and Africa Artemisinine Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Artemisinine Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Artemisinine Revenue Market Share by Country (2016-2021)
Table 38. Global Artemisinine Sales (K Units) by Type (2016-2021)
Table 39. Global Artemisinine Sales Market Share by Type (2016-2021)
Table 40. Global Artemisinine Revenue (Million US$) by Type (2016-2021)
Table 41. Global Artemisinine Revenue Share by Type (2016-2021)
Table 42. Global Artemisinine Price (USD/Unit) by Type (2016-2021)
Table 43. Global Artemisinine Sales (K Units) by Application (2016-2021)
Table 44. Global Artemisinine Sales Market Share by Application (2016-2021)
Table 45. Global Artemisinine Revenue (Million US$) by Application (2016-2021)
Table 46. Global Artemisinine Revenue Share by Application (2016-2021)
Table 47. Global Artemisinine Price (USD/Unit) by Application (2016-2021)
Table 48. Guilin Pharmaceutical Corporation Information
Table 49. Guilin Pharmaceutical Description and Business Overview
Table 50. Guilin Pharmaceutical Artemisinine Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 51. Guilin Pharmaceutical Artemisinine Product
Table 52. Guilin Pharmaceutical Recent Developments/Updates
Table 53. CAT KHANH Corporation Information
Table 54. CAT KHANH Description and Business Overview
Table 55. CAT KHANH Artemisinine Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 56. CAT KHANH Artemisinine Product
Table 57. CAT KHANH Recent Developments/Updates
Table 58. Novanat Bioresource Corporation Information
Table 59. Novanat Bioresource Description and Business Overview
Table 60. Novanat Bioresource Artemisinine Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 61. Novanat Bioresource Artemisinine Product
Table 62. Novanat Bioresource Recent Developments/Updates
Table 63. BEEPZ Corporation Information
Table 64. BEEPZ Description and Business Overview
Table 65. BEEPZ Artemisinine Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 66. BEEPZ Artemisinine Product
Table 67. BEEPZ Recent Developments/Updates
Table 68. KPC Pharmaceuticals Corporation Information
Table 69. KPC Pharmaceuticals Description and Business Overview
Table 70. KPC Pharmaceuticals Artemisinine Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 71. KPC Pharmaceuticals Artemisinine Product
Table 72. KPC Pharmaceuticals Recent Developments/Updates
Table 73. BIONEXX Corporation Information
Table 74. BIONEXX Description and Business Overview
Table 75. BIONEXX Artemisinine Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 76. BIONEXX Artemisinine Product
Table 77. BIONEXX Recent Developments/Updates
Table 78. Guangxi xiancaotang Corporation Information
Table 79. Guangxi xiancaotang Description and Business Overview
Table 80. Guangxi xiancaotang Artemisinine Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 81. Guangxi xiancaotang Artemisinine Product
Table 82. Guangxi xiancaotang Recent Developments/Updates
Table 83. Sanofi Corporation Information
Table 84. Sanofi Description and Business Overview
Table 85. Sanofi Artemisinine Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 86. Sanofi Artemisinine Product
Table 87. Sanofi Recent Developments/Updates
Table 88. Natural Bio-engineering Corporation Information
Table 89. Natural Bio-engineering Description and Business Overview
Table 90. Natural Bio-engineering Artemisinine Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 91. Natural Bio-engineering Artemisinine Product
Table 92. Natural Bio-engineering Recent Developments/Updates
Table 93. Kerui nanhai Corporation Information
Table 94. Kerui nanhai Description and Business Overview
Table 95. Kerui nanhai Artemisinine Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 96. Kerui nanhai Artemisinine Product
Table 97. Kerui nanhai Recent Developments/Updates
Table 98. Production Base and Market Concentration Rate of Raw Material
Table 99. Key Suppliers of Raw Materials
Table 100. Artemisinine Distributors List
Table 101. Artemisinine Customers List
Table 102. Artemisinine Market Trends
Table 103. Artemisinine Growth Drivers
Table 104. Artemisinine Market Restraints
Table 105. Global Artemisinine Sales Forecast by Type (2022-2027) & (K Units)
Table 106. Global Artemisinine Sales Market Share Forecast by Type (2022-2027)
Table 107. Global Artemisinine Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 108. Global Artemisinine Revenue Market Share Forecast by Type (2022-2027)
Table 109. Global Artemisinine Sales Forecast by Application (2022-2027) & (K Units)
Table 110. Global Artemisinine Sales Market Share Forecast by Application (2022-2027)
Table 111. Global Artemisinine Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 112. Global Artemisinine Revenue Market Share Forecast by Application (2022-2027)
Table 113. Global Artemisinine Sales Forecast by Region (2022-2027) & (K Units)
Table 114. Global Artemisinine Sales Market Share Forecast by Region (2022-2027)
Table 115. Global Artemisinine Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 116. Global Artemisinine Revenue Market Share Forecast by Region (2022-2027)
Table 117. Research Programs/Design for This Report
Table 118. Key Data Information from Secondary Sources
Table 119. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Artemisinine
Figure 2. Global Artemisinine Market Share by Type in 2020 & 2027
Figure 3. Extraction from Artemisia annua Product Picture
Figure 4. Semisynthetic Artemisinine Product Picture
Figure 5. Global Artemisinine Market Share by Application in 2020 & 2027
Figure 6. Injections
Figure 7. Tablets
Figure 8. Others
Figure 9. Global Artemisinine Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 10. Global Artemisinine Market Size 2016-2027 (US$ Million)
Figure 11. Global Artemisinine Sales 2016-2027 (K Units)
Figure 12. Global Artemisinine Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 13. Artemisinine Sales Share by Manufacturers in 2020
Figure 14. Global Artemisinine Revenue Share by Manufacturers in 2020
Figure 15. The Global 5 and 10 Largest Artemisinine Players: Market Share by Revenue in 2020
Figure 16. Artemisinine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 17. Global Artemisinine Sales Market Share by Region (2016-2021)
Figure 18. Global Artemisinine Sales Market Share by Region in 2020
Figure 19. Global Artemisinine Revenue Market Share by Region (2016-2021)
Figure 20. Global Artemisinine Revenue Market Share by Region in 2020
Figure 21. U.S. Artemisinine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 22. Canada Artemisinine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 23. Germany Artemisinine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 24. France Artemisinine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 25. U.K. Artemisinine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. Italy Artemisinine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. Russia Artemisinine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. China Artemisinine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. Japan Artemisinine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. South Korea Artemisinine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. India Artemisinine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. Australia Artemisinine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. Taiwan Artemisinine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. Indonesia Artemisinine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. Thailand Artemisinine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Malaysia Artemisinine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Philippines Artemisinine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Vietnam Artemisinine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Mexico Artemisinine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Brazil Artemisinine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Argentina Artemisinine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Turkey Artemisinine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Saudi Arabia Artemisinine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. U.A.E Artemisinine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. Sales Market Share of Artemisinine by Type (2016-2021)
Figure 46. Sales Market Share of Artemisinine by Application (2016-2021)
Figure 47. Sales Market Share of Artemisinine by Application in 2020
Figure 48. Revenue Share of Artemisinine by Application (2016-2021)
Figure 49. Revenue Share of Artemisinine by Application in 2020
Figure 50. Manufacturing Cost Structure of Artemisinine
Figure 51. Manufacturing Process Analysis of Artemisinine
Figure 52. Artemisinine Industrial Chain Analysis
Figure 53. Channels of Distribution
Figure 54. Distributors Profiles
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Figure 57. Key Executives Interviewed

SECONDARY RESEARCH
Secondary Research Information is collected from a number of publicly available as well as paid databases. Public sources involve publications by different associations and governments, annual reports and statements of companies, white papers and research publications by recognized industry experts and renowned academia etc. Paid data sources include third party authentic industry databases.

PRIMARY RESEARCH
Once data collection is done through secondary research, primary interviews are conducted with different stakeholders across the value chain like manufacturers, distributors, ingredient/input suppliers, end customers and other key opinion leaders of the industry. Primary research is used both to validate the data points obtained from secondary research and to fill in the data gaps after secondary research.

MARKET ENGINEERING
The market engineering phase involves analyzing the data collected, market breakdown and forecasting. Macroeconomic indicators and bottom-up and top-down approaches are used to arrive at a complete set of data points that give way to valuable qualitative and quantitative insights. Each data point is verified by the process of data triangulation to validate the numbers and arrive at close estimates.

EXPERT VALIDATION
The market engineered data is verified and validated by a number of experts, both in-house and external.

REPORT WRITING/ PRESENTATION
After the data is curated by the mentioned highly sophisticated process, the analysts begin to write the report. Garnering insights from data and forecasts, insights are drawn to visualize the entire ecosystem in a single report.